Cargando…

Antigen-specific immunotherapy for MOG antibody-associated diseases

Detalles Bibliográficos
Autor principal:	Nessler, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838443/ https://www.ncbi.nlm.nih.gov/pubmed/31590929 http://dx.doi.org/10.1016/j.ebiom.2019.09.029

Ejemplares similares

MOG antibody-associated diseases
por: Reindl, Markus, et al.
Publicado: (2015)

Identification of circulating MOG-specific B cells in patients with MOG antibodies
por: Winklmeier, Stephan, et al.
Publicado: (2019)

MOG-associated encephalitis following SARS-COV-2 infection
por: Peters, John, et al.
Publicado: (2021)

Understanding MOG antibody-associated disease in Brazil
por: Callegaro, Dagoberto, et al.
Publicado: (2023)

Neurological update: MOG antibody disease
por: Wynford-Thomas, Ray, et al.
Publicado: (2018)

Investigating the association between neoplasms and MOG antibody-associated disease
por: Trentinaglia, Milena, et al.
Publicado: (2023)

Cranial nerve involvement in patients with MOG antibody–associated disease
por: Cobo-Calvo, Alvaro, et al.
Publicado: (2019)

No strong HLA association with MOG antibody disease in the UK population
por: Grant‐Peters, Melissa, et al.
Publicado: (2021)

MOG antibody-associated encephalitis secondary to Covid-19: case report
por: Durovic, Ervin, et al.
Publicado: (2021)

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS
por: Kim, Sung-Min, et al.
Publicado: (2015)

Histopathology and clinical course of MOG-antibody-associated encephalomyelitis
por: Spadaro, Melania, et al.
Publicado: (2015)

Predictors of relapse in MOG antibody associated disease: a cohort study
por: Huda, Saif, et al.
Publicado: (2021)

Failure of alemtuzumab therapy in three patients with MOG antibody associated disease
por: Seneviratne, Sinali O., et al.
Publicado: (2022)

Acute haemorrhagic leucoencephalitis as clinical manifestation of MOG antibody-associated disease
por: Skarsta, Laura, et al.
Publicado: (2023)

Humoral signatures of MOG-antibody-associated disease track with age and disease activity
por: Spatola, Marianna, et al.
Publicado: (2023)

Regulatory T Cells Increase After rh-MOG Stimulation in Non-Relapsing but Decrease in Relapsing MOG Antibody-Associated Disease at Onset in Children
por: Horellou, Philippe, et al.
Publicado: (2021)

Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies
por: Yeo, Tianrong, et al.
Publicado: (2020)

Rituximab-Induced Hypogammaglobulinemia and Infections in AQP4 and MOG Antibody–Associated Diseases
por: Avouac, Alexandre, et al.
Publicado: (2021)

Clinical characteristics of MOG antibody disease: two case reports
por: Guan, Yujia, et al.
Publicado: (2021)

International multicenter examination of MOG antibody assays
por: Reindl, Markus, et al.
Publicado: (2020)

COVID-19 vaccine associated demyelination & its association with MOG antibody
por: Netravathi, M., et al.
Publicado: (2022)

Epitope specificity of demyelinating MOG-specific autoantibody responses
por: Brehm, U., et al.
Publicado: (1998)

Brain histopathological study and prognosis in MOG antibody‐associated demyelinating pseudotumor
por: Shu, Yaqing, et al.
Publicado: (2019)

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
por: Jarius, S., et al.
Publicado: (2018)

MOG antibodies in combined central and peripheral demyelination syndromes
por: Vazquez Do Campo, Rocio, et al.
Publicado: (2018)

Bispecific antibodies come to the aid of cancer immunotherapy
por: Amelio, Ivano, et al.
Publicado: (2021)

Identification of TNFAIP3 as relapse biomarker and potential therapeutic target for MOG antibody associated diseases
por: Saxena, Shrishti, et al.
Publicado: (2020)

The Expanding Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Associated Disease in Children and Adults
por: Parrotta, Erica, et al.
Publicado: (2020)

MOG Antibody Disease with Non-Neurological Involvement: A Chance Coincidence or a Relevant Association
por: Porey, Camelia, et al.
Publicado: (2022)

Intractable Hiccup in Demyelinating Disease with Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody
por: Akaishi, Tetsuya, et al.
Publicado: (2016)

Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis
por: Chalmoukou, Konstantina, et al.
Publicado: (2015)

Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination
por: Ramanathan, Sudarshini, et al.
Publicado: (2018)

Reversible paraspinal muscle hyperintensity in anti-MOG antibody–associated transverse myelitis
por: Pandit, Lekha, et al.
Publicado: (2017)

Overlapping central and peripheral nervous system syndromes in MOG antibody–associated disorders
por: Rinaldi, Simon, et al.
Publicado: (2020)

Clinical and imaging features of children with autoimmune encephalitis and MOG antibodies
por: Wegener-Panzer, Andreas, et al.
Publicado: (2020)

Temporal Dynamics of MOG Antibodies in Children With Acquired Demyelinating Syndrome
por: Wendel, Eva Maria, et al.
Publicado: (2022)

Circulating protein and antibody biomarker for personalized cancer immunotherapy
por: Yuan, Jianda
Publicado: (2016)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
por: Jurynczyk, Maciej, et al.
Publicado: (2017)

Frequency of New or Enlarging Lesions on MRI Outside of Clinical Attacks in Patients With MOG-Antibody–Associated Disease
por: Syc-Mazurek, Stephanie B., et al.
Publicado: (2022)

MOG antibody associated disease (MOGAD) presenting with extensive brain stem encephalitis: A case report
por: Olbert, Elisabeth, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s3ghugd14mqb4olu1fgmt6slhp